Novo Nordisk Halts Phase III Ozempic Study on Renal Impairment in Diabetes Patients
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has decided to discontinue a Phase III global...
BMS Expands CAR-T Collaboration with Cellares on Automation Tech
Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a technology transfer agreement with US-based Cellares,...
Henlius Pharmaceutical Secures GMP Compliance for PD-1 Inhibitor Serplulimab in Indonesia
Shanghai Henlius Pharmaceutical Co., Ltd (HKG: 2696) has announced that its partner, PT Kalbe Genexine...
Medilink Therapeutics Enters Global Licensing Agreement with BioNTech for HER3-Targeted Antibody Drug Conjugates
Suzhou-based Medilink Therapeutics has announced a strategic cooperation and global licensing agreement with Germany-headquartered BioNTech...
Jiangsu BioPerfectus Secures NMPA Approval for Norovirus Nucleic Acid Detection Kit
China-based Jiangsu BioPerfectus Technologies Co., Ltd (SHA: 688399), a leading manufacturer of in vitro diagnostic...
Kintor Pharmaceutical Secures NMPA Approval for Phase II Study of GT1708F in Idiopathic Pulmonary Fibrosis
China-based Kintor Pharmaceutical Ltd (HKG: 9939) has announced that it has received approval from the...
Yiling Pharmaceutical Secures NMPA Approval for Phase I Study of G201-Na in Premenopausal Women
China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced that it has received approval from...
Gritgen Therapeutics Commences Operations of Commercial GMP Facilities in Suzhou
Suzhou-based gene therapy specialist, Gritgen Therapeutics Co., Ltd, has announced the validation completion and initiation...
GenFleet Therapeutics’ CDK9 Inhibitor SLS009 Earns Orphan Drug Status for AML
Shanghai-based biotechnology company GenFleet Therapeutics has announced that its CDK9 inhibitor, SLS009 (GFH009), has received...
Cochlear’s Artificial Cochlear Sound Processor Gains NMPA Approval for Marketing in China
Australia-based Cochlear has received marketing approval from the National Medical Products Administration (NMPA) for its...
Jiangsu Recbio Forms Strategic Cooperation for Vaccine Production in Zimbabwe
China-based Jiangsu Recbio Technology Co., Ltd (HKG: 2179) has announced a tripartite strategic cooperation agreement...
Roche’s Forimtamig Receives Tacit Approval for Multiple Myeloma Clinical Trials
The Center for Drug Evaluation (CDE) has indicated that Swiss pharmaceutical giant Roche (SWX: ROG)...
Sanofi Partners with BioMap to Accelerate AI-Driven Drug Discovery
France-based pharmaceutical giant Sanofi (EPA: SAN) has entered into a strategic partnership with US biotech...
Sino Biopharmaceutical Sells 84.2% Stake in Shanghai CP General Pharmaceutical
China-based biotech company Sino Biopharmaceutical Ltd (HKG: 1177) has announced the sale of an 84.2%...
Jiangsu QYuns Therapeutics Plans IPO on Hong Kong Stock Exchange
China-based Jiangsu QYuns Therapeutics Co., Ltd (HKG: 2509) has announced its intention to pursue an...
Janssen Unveils Promising Clinical Data on IL-23 Blockers for Psoriasis
The Janssen unit of Johnson & Johnson (J&J; NYSE: JNJ) is showcasing new clinical data...
MicroPort Secures Market Approvals for ULYS ICDs and INVICTA Leads in Japan
Shanghai-based MicroPort Scientific Corp. (HKG: 0853) has announced that its France-based subsidiary, MicroPort Cardiac Rhythm...
Hainan Implements New Regulations for Import Drugs and Medical Devices in Medical Tourism Zone
The Hainan Medical Products Administration, in conjunction with Hainan’s Health Commission Bureau, has unveiled a...
Bayer Opens First Cell Therapy Production Facility in the U.S. to Advance Research
Bayer AG (ETR: BAYN) has inaugurated its first production site dedicated to cell therapies, marking...
AstraZeneca Seeks Approval for Capivasertib in Combination with Faslodex for Breast Cancer Treatment
AstraZeneca (AZ, NASDAQ: AZN) has submitted a market approval filing for its Category 1 drug...